Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 33.77B | 28.57B | 26.84B | 27.30B | 27.69B |
Gross Profit | 4.31B | 3.77B | 3.37B | 4.27B | 4.75B |
EBITDA | 4.01B | 1.40B | 879.00M | 1.65B | 2.39B |
Net Income | 2.19B | 415.00M | 123.00M | 775.00M | 1.33B |
Balance Sheet | |||||
Total Assets | 37.76B | 33.67B | 28.79B | 27.79B | 25.05B |
Cash, Cash Equivalents and Short-Term Investments | 3.08B | 2.20B | 2.32B | 3.25B | 1.48B |
Total Debt | 10.78B | 9.02B | 6.45B | 4.95B | 4.69B |
Total Liabilities | 25.44B | 23.26B | 18.86B | 17.96B | 15.73B |
Stockholders Equity | 12.31B | 10.41B | 9.93B | 9.83B | 9.31B |
Cash Flow | |||||
Free Cash Flow | -4.03B | -2.51B | -2.21B | 2.32B | -1.01B |
Operating Cash Flow | -2.33B | -1.09B | -1.16B | 3.15B | -137.00M |
Investing Cash Flow | 1.70B | -1.46B | -1.10B | -1.08B | -878.00M |
Financing Cash Flow | 1.51B | 2.42B | 1.33B | -287.00M | 912.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥10.94B | 5.06 | 2.01% | 24.64% | 35.00% | ||
80 Outperform | ¥14.04B | 7.54 | 1.21% | 23.15% | 46.68% | ||
75 Outperform | ¥10.58B | 10.27 | 4.49% | 3.49% | 9.50% | ||
74 Outperform | ¥3.99B | 8.11 | 2.65% | -21.00% | -7.27% | ||
64 Neutral | $10.95B | 16.37 | 8.81% | 1.96% | 2.68% | -15.33% | |
63 Neutral | ¥9.58B | 3.81 | 2.39% | 12.27% | 682.78% | ||
61 Neutral | ¥11.56B | 200.06 | ― | 6.02% | -49.16% |